Drug Executive Collapses During Oval Office Press Conference
During a press conference in the Oval Office, a drug executive fainted while President Donald Trump announced a deal with drugmakers to reduce obesity drug prices.
Incident Details
The event, held on Thursday, was focused on a partnership between the government and pharmaceutical companies Eli Lilly and Novo Nordisk. The deal aimed to expand coverage and lower prices for popular obesity medications Zepbound and Wegovy.
David Ricks, CEO of Eli Lilly, was speaking when he noticed the incident and asked,
"Are you OK? Gordon, are you OK?"
Key Figures Involved
- The man who collapsed was identified as Gordon Findlay, the global brand director for Novo Nordisk.
- Dr. Mehmet Oz, Administrator for the Centers for Medicare & Medicaid Services, quickly assisted Findlay as he fell.
- Health and Human Services Secretary was also present during the incident.
Aftermath
Following the collapse, the press was promptly asked to leave, and the event was cut short.
Getty Images, which covered the event, confirmed the identity of the man who fainted as Gordon Findlay.
Summary: A drug executive collapsed during a high-profile press briefing at the Oval Office where President Trump announced a drug pricing deal, receiving immediate aid from CMS Administrator Dr. Oz.
Would you like the summary to be more formal or conversational?